FASEB J. Thermo Fisher Scientific
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Klaassen, C. D.
Right arrow Articles by Boles, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Klaassen, C. D.
Right arrow Articles by Boles, J. W.

The FASEB Journal, Vol 11, 404-418, Copyright © 1997 by The Federation of American Societies for Experimental Biology

REVIEWS

Sulfation and sulfotransferases 5: the importance of 3'- phosphoadenosine 5'-phosphosulfate (PAPS) in the regulation of sulfation

CD Klaassen and JW Boles
Center for Environmental and Occupational Health, University of Kansas Medical Center, Kansas City 66160-7417, USA.

Sulfation is the transfer of a sulfate group from 3'-phosphoadenosine 5'-phosphosulfate (PAPS) to a substrate that is catalyzed by a family of sulfotransferase enzymes. Many different endogenous and xenobiotic molecules are substrates for the sulfotransferases; sulfation affects many different physiological processes, including: 1) deactivation and bioactivation of xenobiotics, 2) inactivation of hormones and catecholamines, 3) structure and function of macromolecules, and 4) elimination of end products of catabolism. PAPS is the obligate cosubstrate that is synthesized in tissues to make available an "activated form" of sulfate for the sulfation reaction. PAPS participation in the reaction is dependent on its availability, which in turn is dependent on its synthesis, degradation, and ultimately its utilization in the sulfation reaction itself. PAPS synthesis is dependent on the availability of sulfate and on the activity of the two enzymes of its synthesis, ATP-sulfurylase and APS-kinase. Although the kinetic properties of these two enzymes are well described, their in vivo regulation is not fully understood. Sulfation is a high-affinity, low-capacity enzymatic process in which the entire liver content of PAPS can be consumed in less than 2 min. ATP-sulfurylase and APS-kinase can rapidly synthesize additional PAPS. The low capacity of sulfation in rats is due to the limited availability of sulfate, whereas in mice the sulfotransferases appear to limit sulfation capacity. Sulfation rates are not readily enhanced, but they can be decreased. 2,6-Dichloro- 4-nitrophenol inhibits phenolsulfotransferases, but not hydroxysteroid- sulfotransferases. However, the sulfation of phenols and hydroxysteroids can be decreased by factors that decrease sulfate availability such as a low-sulfate diet, other xenobiotics that are sulfated, and molybdate, which inhibits sulfate intestinal absorption, renal reabsorption, and sulfate incorporation into PAPS.


This article has been cited by other articles:


Home page
 J. Cell Biol.Home page
L. L. Galante and J. E. Schwarzbauer
Requirements for sulfate transport and the diastrophic dysplasia sulfate transporter in fibronectin matrix assembly
J. Cell Biol., December 3, 2007; 179(5): 999 - 1009.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
N. Sekulic, M. Konrad, and A. Lavie
Structural Mechanism for Substrate Inhibition of the Adenosine 5'-Phosphosulfate Kinase Domain of Human 3'-Phosphoadenosine 5'-Phosphosulfate Synthetase 1 and Its Ramifications for Enzyme Regulation
J. Biol. Chem., July 27, 2007; 282(30): 22112 - 22121.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. E. Lauer, V. C. Hascall, and A. Wang
Heparan Sulfate Analysis from Diabetic Rat Glomeruli
J. Biol. Chem., January 12, 2007; 282(2): 843 - 852.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
N. Gamage, A. Barnett, N. Hempel, R. G. Duggleby, K. F. Windmill, J. L. Martin, and M. E. McManus
Human Sulfotransferases and Their Role in Chemical Metabolism
Toxicol. Sci., March 1, 2006; 90(1): 5 - 22.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
U. Mechold, V. Ogryzko, S. Ngo, and A. Danchin
Oligoribonuclease is a common downstream target of lithium-induced pAp accumulation in Escherichia coli and human cells.
Nucleic Acids Res., January 1, 2006; 34(8): 2364 - 2373.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
A. M. Zavacki and P. R. Larsen
CARs and Drugs: A Risky Combination
Endocrinology, March 1, 2005; 146(3): 992 - 994.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
M. Qatanani, J. Zhang, and D. D. Moore
Role of the Constitutive Androstane Receptor in Xenobiotic-Induced Thyroid Hormone Metabolism
Endocrinology, March 1, 2005; 146(3): 995 - 1002.
[Abstract] [Full Text] [PDF]

Home page
 J Exp BotHome page
M. Klein and J. Papenbrock
The multi-protein family of Arabidopsis sulphotransferases and their relatives in other plant species
J. Exp. Bot., August 1, 2004; 55(404): 1809 - 1820.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
I. Echchgadda, C. S. Song, A. K. Roy, and B. Chatterjee
Dehydroepiandrosterone Sulfotransferase Is a Target for Transcriptional Induction by the Vitamin D Receptor
Mol. Pharmacol., March 1, 2004; 65(3): 720 - 729.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
S. Fadel and A. Eley
Chlorate: a reversible inhibitor of proteoglycan sulphation in Chlamydia trachomatis-infected cells
J. Med. Microbiol., February 1, 2004; 53(2): 93 - 95.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
E. Chapman, M. C. Bryan, and C.-H. Wong
Mechanistic studies of beta -arylsulfotransferase IV
PNAS, February 4, 2003; 100(3): 910 - 915.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
C. A. Strott
Sulfonation and Molecular Action
Endocr. Rev., October 1, 2002; 23(5): 703 - 732.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
D. Beaujean, J.-L. Do-Rego, L. Galas, A. G. Mensah-Nyagan, R. Fredriksson, D. Larhammar, A. Fournier, V. Luu-The, G. Pelletier, and H. Vaudry
Neuropeptide Y Inhibits the Biosynthesis of Sulfated Neurosteroids in the Hypothalamus through Activation of Y1 Receptors
Endocrinology, May 1, 2002; 143(5): 1950 - 1963.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
D. Markovich
Physiological Roles and Regulation of Mammalian Sulfate Transporters
Physiol Rev, October 1, 2001; 81(4): 1499 - 1533.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
M. W. H. Coughtrie and L. E. Johnston
Interactions between Dietary Chemicals and Human Sulfotransferases{---}Molecular Mechanisms and Clinical Significance
Drug Metab. Dispos., April 1, 2001; 29(4): 522 - 528.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
W. Honma, Y. Kamiyama, K. Yoshinari, H. Sasano, M. Shimada, K. Nagata, and Y. Yamazoe
Enzymatic Characterization and Interspecies Difference of Phenol Sulfotransferases, ST1A Forms
Drug Metab. Dispos., March 1, 2001; 29(3): 274 - 281.
[Abstract] [Full Text]

Home page
 Drug Metab. Dispos.Home page
Z.-H. Xu, T. C. Wood, A. A. Adjei, and R. M. Weinshilboum
Human 3'-Phosphoadenosine 5'-Phosphosulfate Synthetase: Radiochemical Enzymatic Assay, Biochemical Properties, and Hepatic Variation
Drug Metab. Dispos., February 1, 2001; 29(2): 172 - 178.
[Abstract] [Full Text]

Home page
 GlycobiologyHome page
S. Hemmerich and S. D. Rosen
MINI REVIEW Carbohydrate sulfotransferases in lymphocyte homing
Glycobiology, September 1, 2000; 10(9): 849 - 856.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
C. Agus, K. F. Ilett, F. F. Kadlubar, and R. F. Minchin
Characterization of an ATP-dependent pathway of activation for the heterocyclic amine carcinogen N-hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline
Carcinogenesis, June 1, 2000; 21(6): 1213 - 1219.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
S. BESSET, J.-B. VINCOURT, F. AMALRIC, and J.-P. GIRARD
Nuclear localization of PAPS synthetase 1: a sulfate activation pathway in the nucleus of eukaryotic cells
FASEB J, February 1, 2000; 14(2): 345 - 354.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
R. Dajani, A. Cleasby, M. Neu, A. J. Wonacott, H. Jhoti, A. M. Hood, S. Modi, A. Hersey, J. Taskinen, R. M. Cooke, et al.
X-ray Crystal Structure of Human Dopamine Sulfotransferase, SULT1A3. MOLECULAR MODELING AND QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS DEMONSTRATE A MOLECULAR BASIS FOR SULFOTRANSFERASE SUBSTRATE SPECIFICITY
J. Biol. Chem., December 31, 1999; 274(53): 37862 - 37868.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Safaiyan, S. O. Kolset, K. Prydz, E. Gottfridsson, U. Lindahl, and M. Salmivirta
Selective Effects of Sodium Chlorate Treatment on the Sulfation of Heparan Sulfate
J. Biol. Chem., December 17, 1999; 274(51): 36267 - 36273.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. T. Dunn II, B. A. Gleason, D. P. Hartley, and C. D. Klaassen
Postnatal Ontogeny and Hormonal Regulation of Sulfotransferase SULT1B1 in Male and Female Rats
J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 319 - 324.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
J. M. Lopez-Coronado, J. M. Belles, F. Lesage, R. Serrano, and P. L. Rodriguez
A Novel Mammalian Lithium-sensitive Enzyme with a Dual Enzymatic Activity, 3'-Phosphoadenosine 5'-Phosphate Phosphatase and Inositol-polyphosphate 1-Phosphatase
J. Biol. Chem., June 4, 1999; 274(23): 16034 - 16039.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
R. Dajani, A. M. Hood, and M. W. H. Coughtrie
A Single Amino Acid, Glu146, Governs the Substrate Specificity of a Human Dopamine Sulfotransferase, SULT1A3
Mol. Pharmacol., December 1, 1998; 54(6): 942 - 948.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
B. Schneider, Y. W. Xu, J. Janin, M. Veron, and D. Deville-Bonne
3'-Phosphorylated Nucleotides Are Tight Binding Inhibitors of Nucleoside Diphosphate Kinase Activity
J. Biol. Chem., October 30, 1998; 273(44): 28773 - 28778.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
J.-P. Girard, E. S. Baekkevold, and F. Amalric
Sulfation in high endothelial venules: cloning and expression of the human PAPS synthetase
FASEB J, May 1, 1998; 12(7): 603 - 612.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by The Federation of American Societies for Experimental Biology.